(1) Hyperviscosity statese.g., Waldenström's macroglobulinemia; (2) TTP; (3) immune-complex and autoantibody disorderse.g., Goodpasture's syndrome, rapidly progressive glomerulonephritis, myasthenia gravis; possibly Guillain-Barré, systemic lupus erythematosus, idiopathic thrombocytopenic purpura; (4) cold agglutinin disease, cryoglobulinemia. In plasma exchange, abnormal proteins are removed and normal plasma or plasma components are replaced; useful in TTP to remove anti-ADAMTS13 antibody and provide normal ADAMTS13 levels.
For a more detailed discussion, see Dzieczkowski JS, Anderson KC: Transfusion Biology and Therapy, Chap. 138e, in HPIM-19. |
Section 1. Care of the Hospitalized Patient